🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, placebo-controlled trial will evaluate the i...
Status
Completed
Location
Center of New Medical Technologies
Start Date
2022-03-02
Trial ID
NCT06163443
The purpose of this study is to compare the efficacy and safety of sitravat...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-06-30
Trial ID
NCT05564338
Treatments Being Tested
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested
RV568 is being developed as a possible treatment of smoking related lung di...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01661244
This study is researching an experimental drug called ALN-APOC3 (called "st...
Status
Completed
Location
Arensia Exploratory Medicine at the Republican Clinical Hospital
Start Date
2025-01-27
Trial ID
NCT06784349
Treatments Being Tested
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
The study evaluates the safety of different doses of a new medicine called ...
Status
Recruiting
Location
N America Res Inst - San Dimas
Start Date
2024-12-02
Trial ID
NCT06717698
Treatments Being Tested
This is a 24-week study investigating the safety and efficacy of several do...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-28
Trial ID
NCT00111800
Treatments Being Tested
This Phase I Clinical Study assessed the Safety, Tolerability, Pharmacokine...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2023-03-02
Trial ID
NCT05668403
This is a Phase I Randomised Single-blind Placebo-controlled Study to Asses...
Status
Completed
Location
Research Site
Start Date
2023-05-02
Trial ID
NCT05848440